BMS to acquire ZymoGenetics
September 8, 2010Research and Development, Sales and Marketing BMS, hepatitis
Bristol-Myers Squibb is to acquire biopharma company ZymoGenetics for $885 million to add to its ‘string of pearls’of small biotech …
GSK patient recruitment head joins Exco InTouch
September 8, 2010Research and Development Exco InTouch, appointment, research and development
Judith Teall has been appointed director of patient recruitment at clinical trial technology company Exco InTouch. She has spent more …
Working Life: Dr Meena Jain
September 8, 2010Business Services, Research and Development Napp, Working Life, careers, recruitment
How did you find your way into your most current role? I’ve been at Napp for four years now having …
PCT managers have ‘no automatic right’ to GP commissioning
September 8, 2010GP, NHS, commissioning, government
Primary care trust managers should not have a legal right to transfer to similar roles in GP commissioning groups, according …
Pfizer drops brain cancer vaccine
September 7, 2010Research and Development Celldex Therapeutics, Pfizer, cancer vaccine
Pfizer has dropped its experimental brain cancer vaccine rindopepimut, handing back worldwide rights to Celldex Therapeutics from November. Rindopepimut targets …
Roche signs Alzheimer’s deal with reMYND
September 7, 2010Research and Development Alzheimer's, Parkinson's, Roche, reMYND
Roche has signed a deal with Belgian biotech reMYND to develop new treatments for patients with Alzheimer’s and Parkinson’s disease. …
Merck averts day in court over Dutch plant closure
September 7, 2010Manufacturing and Production, Research and Development Merck & Co, Netherlands, job cuts
Merck & Co has postponed the planned closure of the former Organon facility in Oss, the Netherlands, after weeks of …
FDA cites another Sun Pharma unit for GMP violations
September 7, 2010Manufacturing and Production Sun Pharma, manufacturing compliance
Sun Pharmaceuticals’ manufacturing operations have been found wanting by FDA for the second time in recent months, once again for …
Pharma manufacturing news in brief
September 7, 2010Manufacturing and Production Aegis Protek, Alexion, Halozyme, Ranbaxy, SemBioSys
A round-up of pharma manufacturing developments from Ranbaxy, SemBioSys, Halozyme, Aegis Protek, Alexion and Thomson/Rondaxe. Ranbaxy Laboratories of India has …
Stephen Stamp joins board at Eusa Pharma
September 7, 2010Sales and Marketing Eusa Pharma, appointment, sales and marketing
Transatlantic specialty company Eusa Pharma has appointed Stephen Stamp to its board as an independent non-executive director. Stephen has previously …
Russian API manufacturer eyes IPO and acquisitions
September 7, 2010Manufacturing and Production API, Pharmsynthez, Russia
Russian active pharmaceutical ingredient manufacturer Pharmsynthez is planning a listing on the MICEX stock exchange to help it expand beyond …
New form of Levitra wins EU approval
September 7, 2010Sales and Marketing Bayer, Levitra, erectile dysfunction
Bayer is to launch a new formulation of its erectile dysfunction drug Levitra. The European Commission granted Levitra (verdenafil HCI) …
Pressure mounts on GSK over Avandia
September 6, 2010Sales and Marketing Avandia, GlaxoSmithKline
GlaxoSmithKline is under mounting pressure this week as calls intensify for its type II diabetes drug Avandia to be withdrawn …
Parallel trading restricting medicine access, says ABPI
September 6, 2010Sales and Marketing parallel trade, pharmacists, supply chain
The ABPI has blamed parallel trading by a minority of pharmacists as the root cause of the current medicines shortage …
Next generation Malaria drug shows promise
September 6, 2010Research and Development malaria
A Novartis-led collaboration has discovered a novel anti-malarial candidate that could become the first new treatment for the disease in …
Olivier Bohuon takes post at Pierre Fabre
September 6, 2010Sales and Marketing Pierre Fabre, appointment, sales and marketing
French pharma company Pierre Fabre has officially appointed Olivier Bohuon to take over from Jean-Pierre Garnier as chief executive. Olivier’s …
Sanofi’s Multaq in pole position for AF market
September 6, 2010Sales and Marketing Multaq, Sanofi-Aventis, atrial fibrilation
New European Society of Cardiology guidelines on treating atrial fibrillation (AF) include a recommendation for Sanofi-Aventis’ Multaq. The endorsement is …
Pradaxa, Xarelto and apixaban vie for attention
September 6, 2010Research and Development, Sales and Marketing Pradaxa, Xarelto, apixaban, atrial fibrilation
New data has intensified the competition between three rival would-be cardiology blockbusters. Boehringer Ingelheim’s Pradaxa (dabigatran) and Bayer’s Xarelto (rivaroxaban) …
Watchdog resignation forced ‘to appease pharma’
September 6, 2010Sales and Marketing Germany, IQWIG
The head of Germany’s medicines cost-effectiveness watchdog was forced to resign because he was a vocal critic of the pharma …
Huntsworth makes European strategy appointment
September 3, 2010Medical Communications Huntsworth, appointment, medical communications
UK communications company Huntsworth Health has appointed Annabelle Sandeman as European Director Strategic Development. She will report to chief executive …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
